United Therapeutics Corporation (UTHR)

United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	16,401	10,333	12,674	9,731	6,746	3,865
Market Cap Growth	50.40%	-18.47%	30.24%	44.26%	74.53%	-18.57%
Enterprise Value	12,195	6,197	9,415	7,022	4,738	2,569
Last Close Price	367.36	219.89	278.09	216.08	151.79	88.08
PE Ratio	16.17	10.49	17.43	20.45	13.10	-
Forward PE	12.67	9.93	13.56	13.45	11.39	7.27
PS Ratio	6.10	4.44	6.55	5.77	4.55	2.67
PB Ratio	2.69	1.73	2.64	2.46	1.99	1.39
P/TBV Ratio	2.66	1.76	2.67	2.49	2.08	1.47
P/FCF Ratio	18.26	13.82	19.10	20.38	9.69	-
P/OCF Ratio	14.43	10.57	15.79	16.27	8.93	-
PEG Ratio	0.88	13.47	1.03	0.72	1.27	1.45
EV/Sales Ratio	4.42	2.66	4.86	4.17	3.19	1.77
EV/EBITDA Ratio	8.64	5.00	9.05	9.53	7.33	-
EV/EBIT Ratio	9.06	5.23	9.52	10.22	7.94	-
EV/FCF Ratio	13.58	8.29	14.19	14.71	6.80	-
Debt / Equity Ratio	0.07	0.12	0.17	0.20	0.24	0.31
Debt / EBITDA Ratio	0.28	0.59	0.77	1.09	1.24	-
Debt / FCF Ratio	0.45	0.98	1.21	1.68	1.15	-
Asset Turnover	0.39	0.35	0.35	0.34	0.35	0.40
Inventory Turnover	2.43	2.41	1.55	1.36	1.20	1.21
Quick Ratio	4.20	4.09	9.12	6.97	6.16	3.54
Current Ratio	4.58	4.41	9.85	7.61	6.70	4.03
Return on Equity (ROE)	18.81%	18.27%	16.61%	12.94%	16.67%	-3.75%
Return on Assets (ROA)	11.89%	11.22%	11.02%	8.78%	8.74%	-3.04%
Return on Capital (ROIC)	12.93%	12.04%	11.94%	9.59%	9.53%	-3.33%
Earnings Yield	6.77%	9.53%	5.74%	4.89%	7.63%	-2.70%
FCF Yield	5.48%	7.23%	5.24%	4.91%	10.32%	-7.51%
Buyback Yield / Dilution	1.36%	-2.47%	-2.54%	-6.05%	-1.83%	0.45%
Total Shareholder Return	1.36%	-2.47%	-2.54%	-6.05%	-1.83%	0.45%

Source: S&P Capital IQ. Standard template. Financial Sources.